AN2 Therapeutics Inc (ANTX)
1.34
+0.11
(+8.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.34
0.00 (0.00%)
After-Hours: 20:00
AN2 Therapeutics Total Liabilities (Quarterly): 10.02M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.02M |
| June 30, 2024 | 10.13M |
| March 31, 2024 | 10.66M |
| December 31, 2023 | 14.04M |
| September 30, 2023 | 14.84M |
| June 30, 2023 | 11.16M |
| Date | Value |
|---|---|
| March 31, 2023 | 8.567M |
| December 31, 2022 | 7.188M |
| September 30, 2022 | 4.435M |
| June 30, 2022 | 4.153M |
| March 31, 2022 | 5.093M |
| December 31, 2021 | 3.408M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.408M
Minimum
Dec 2021
14.84M
Maximum
Sep 2023
8.641M
Average
9.292M
Median
Total Liabilities (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 1.438B |
| Arbutus Biopharma Corp | 33.55M |
| GlycoMimetics Inc | 4.322M |
| FibroGen Inc | 466.12M |
| Cidara Therapeutics Inc | 46.70M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 97.69M |
| Shareholders Equity (Quarterly) | 87.67M |